Abstract
Candida-associated denture stomatitis has a high rate of recurrence. Candida biofilms formed on denture acrylic are more resistant to antifungals than planktonic yeasts. Histatins, a family of basic peptides secreted by the major salivary glands in humans, especially histatin 5, possess significant antifungal properties. We examined antifungal activities of histatin 5 against planktonic or biofilm Candida albicans and Candida glabrata. Candida biofilms were developed on poly(methyl methacrylate) discs and treated with histatin 5 (0.01–100 μM) or fluconazole (1–200 μM). The metabolic activity of the biofilms was measured by the XTT reduction assay. The fungicidal activity of histatin 5 against planktonic Candida was tested by microdilution plate assay. Biofilm and planktonic C. albicans GDH18, UTR-14 and 6122/06 were highly susceptible to histatin 5, with 50% RMA (concentration of the agent causing 50% reduction in the metabolic activity; biofilm) of 4.6 ± 2.2, 6.9 ± 3.7 and 1.7 ± 1.5 μM, and IC50 (planktonic cells) of 3.0 ± 0.5, 2.6 ± 0.1 and 4.8 ± 0.5, respectively. Biofilms of C. glabrata GDH1407 and 6115/06 were less susceptible to histatin 5, with 50% RMA of 31.2 ± 4.8 and 62.5 ± 0.7 μM, respectively. Planktonic C. glabrata was insensitive to histatin 5 (IC50 > 100 μM). Biofilm-associated Candida was highly resistant to fluconazole in the range 1–200 μM; e.g. at 100 μM only ~20% inhibition was observed for C. albicans, and ~30% inhibition for C. glabrata. These results indicate that histatin 5 exhibits antifungal activity against biofilms of C. albicans and C. glabrata developed on denture acrylic. C. glabrata is significantly less sensitive to histatin 5 than C. albicans.
References
Campos MS, Marchini L, Bernardes LAS, Paulino LC, Nobrega FG (2008) Biofilm microbial communities of denture stomatitis. Oral Microbiol Immunol 23:419–424
Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA (2001a) Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183:5385–5394. doi:10.1128/JB.183.18.5385-5394.2001
Chandra J, Mukherjee PK, Leidich SD, Faddoul FF, Hoyer LL, Douglas LJ, Ghannoum MA (2001b) Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 80:903–908. doi:10.1177/00220345010800031101
Coco BJ, Bagg J, Cross LJ, Jose A, Cross J, Ramage G (2008) Mixed Candida albicans and Candida glabrata populations associated with the pathogenesis of denture stomatitis. Oral Microbiol Immunol 23:377–383
Douglas LJ (2003) Candida biofilms and their role in infection. Trends Microbiol 11:30–36
Edgerton M, Rai PA, Levine MJ (1995) Surface-modified poly(methyl methacrylate) enhances adsorption and retains anticandidal activities of salivary histatin 5. J Biomed Mater Res 29:1277–1286
Edgerton M, Koshlukova SE, Lo TE, Chrzan BC, Straubinger RM, Raj PA (1998) Candidacidal activity of salivary histatins. Identification of histatin 5-binding protein on Candida albicans. J Biol Chem 273:20438–20447
Göcke R, Gerath F, von Schwanewede H (2002) Quantitative determination of salivary components in the pellicle on PMMA denture based material. Clin Oral Investig 6:227–235
Gyurko C, Lendenmann U, Helmerhorst EJ, Troxler RF, Oppenheim FG (2001) Killing of Candida albicans by histatin 5: cellular uptake and energy requirement. Antonie van Leeuwenhoek 79:297–309
Helmerhorst EJ, Reijnders IM, Van’t Hof W, Simoons-Smit I, Veerman ECI ECI, Nieuw Amerongen AV (1999) Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrob Agents Chemother 43:702–704
Helmerhorst EJ, Troxler FG, Oppenheim FG (2001) The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species. Proc Natl Acad Sci USA 98:14637–14642
Helmerhorst EJ, Venuleo C, Beri A, Oppenheim FG (2005) Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins. Yeast 22:705–714. doi:10.1002/yea.1241
Jang WS, Li XS JN, Sun JN, Edgerton M (2008) The P-113 fragment of histatin 5 requires a specific peptide sequence for intracellular translocation in Candida albicans, which is independent of cell wall binding. Antimicrob Agents Chemother 52:497–504. doi:10.1128/AAC.01199-07
Kavanagh K, Dowd S (2004) Histatins: antimicrobial peptides with therapeutic potential. J Pharm Pharmacol 56:285–289. doi:10.1211/0022357022971
Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA (2002) Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46:1773–1780. doi:10.1128/AAC.46.6.1773-1780.2002
Li L, Redding S, Dongari-Bagtzoglou A (2007) Candida glabrata, an emerging oral opportunistic pathogen. J Dent Res 86:204–215. doi:10.1177/154405910708600304
Luo G, Samaranayake LP (2002) Candida glabrata, an emerging fungal pathogen, exhibits superior relative cell surface hydrophobicity and adhesion to denture acrylic surfaces compared with Candida albicans. APMIS 110:601–610
Nikawa H, Jin C, Fukushima H, Makihira S, Hamada T (2001) Antifungal activity of histatin-5 against non-albicans Candida species. Oral Microbiol Immunol 16:250–252
Pereira-Cenci T, Del Bel Cury AA, Crielaard W, Ten Cate JM (2008) Development of Candida-associated denture stomatitis: new insights. J Appl Oral Sci 16:86–94
Pusateri CR, Monaco EA, Edgerton M (2009) Sensitivity of Candida albicans biofilm cells grown on denture acrylic to antifungal proteins and chlorhexidine. Arch Oral Biol 54:588–594
Ramage G, Tomsett K, Wickes BK, Lopez-Ribot JL, Redding SW (2004) Denture stomatitis: a role of Candida biofilms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:53–59
Situ H, Bobek LA (2000) In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1. Antimicrob Agents Chemother 444:1485–1493
Tsai H, Bobek LA (1997) Studies on the mechanism of human salivary histatin 5 candidacidal activity with histatin 5 variants and azole-sensitive and -resistant Candida species. Antimicrob Agents Chemother 41:2224–2228
Xu T, Levitz SM, Diamond RD, Oppenheim FG (1991) Anticandidal activity of major human salivary histatins. Infect Immun 59:2549–2554
Yoshinari M, Kato T, Matsuzaka K, Hayakawa T, Inoue T, Oda Y, Okuda K, Shimono M (2006) Adsorption behavior of antimicrobial peptide histatin 5 on PMMA. J Biomed Mater Res B Appl Biomater 77B:47–54. doi:10.1002/jbm.b.30393
Acknowledgments
This work was supported in part by Research Pilot Project Award 03-Activity 054 from the University of the Pacific, Arthur A. Dugoni School of Dentistry (K. Konopka). We thank M. Yee for technical assistance and Dr. L. Samaranayake for leading us to Hing Lung Engineering Inc. for the manufacture of acrylic discs.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Konopka, K., Dorocka-Bobkowska, B., Gebremedhin, S. et al. Susceptibility of Candida biofilms to histatin 5 and fluconazole. Antonie van Leeuwenhoek 97, 413–417 (2010). https://doi.org/10.1007/s10482-010-9417-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10482-010-9417-5